Highlights
Kyverna Therapeutics Granted FDA Fast Track Designation for KYV-101 in the Treatment of Pa
EMERYVILLE, Calif., Jan. 19, 2024. Kyverna Therapeutics, Inc. (Kyverna), a patient-centered clinical-stage biopharmaceut
Coperion optimises extruder design for greater flexibility
Coperion has equipped its ZSK 18 MEGAlab laboratory extruder with numerous new functions that are designed to provide gr
Regulatory Update — Week of Jan. 15, 2024
nl Over the past week, the FDA issued final guidance on drug security at the package level and announced a meet
Bidirectional Link ID'd for Autoimmune Disease, Perinatal Depression
FRIDAY, Jan. 19, 2024 -- There is a bidirectional association between autoimmune disease (AD) and perinatal depression (
COVID-19 Vaccine Uptake More Likely in Pregnancy if Receiving Other Vaccines
FRIDAY, Jan. 19, 2024 -- Pregnant patients are more likely to accept COVID-19 vaccination if they receive other routine
Possible Link Found Between Video Gaming, Hearing Loss/Tinnitus
FRIDAY, Jan. 19, 2024 -- Video gaming may be associated or correlated with hearing loss and/or tinnitus, according to a
Clinical Practice Guideline Developed for Management of Pouchitis
FRIDAY, Jan. 19, 2024 -- In a clinical practice guideline issued by the American Gastroenterological Association (AGA) a
Nuance AI copilot now fully embedded in Epic EHR
More than 150 hospitals and health systems currently use the DAX Copilot in their Epic electronic health record workflow
Drug Safety Communication: Prolia (denosumab) - FDA Adds Boxed Warning for Increased Risk
Audience: Patient, Health Professional, Endocrinology, Nephrology, Pharmacy January 19, 20204 -- Based on a completed FD
MedAccred Sterilization Town Hall united industry specialists
In a virtual event on 13th December 2023, the medical device industry joined together to work towards enhancing steri
Climate Change Could Cut Global Life Spans by Half a Year
FRIDAY, Jan. 19, 2024 -- The effects of climate change could be shaving half a year off your life, a new study warns.n